NCT07060014 2025-07-11NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal CancersThe Methodist Hospital Research InstitutePhase 1 Not yet recruiting22 enrolled